Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China
· Delayed Price · Currency is CNY 25.99
+0.24 (0.93%)
Mar 10, 2026, 2:14 PM CST
Aurisco Pharmaceutical Revenue
Aurisco Pharmaceutical had revenue of 415.09M CNY in the quarter ending September 30, 2025, with 16.05% growth. This brings the company's revenue in the last twelve months to 1.62B, up 13.73% year-over-year. In the year 2024, Aurisco Pharmaceutical had annual revenue of 1.48B with 16.89% growth.
Revenue (ttm)
1.62B
Revenue Growth
+13.73%
P/S Ratio
6.44
Revenue / Employee
910.58K
Employees
1,784
Market Cap
10.46B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Liaoning Chengda Biotechnology | 1.39B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.96B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.94B |
| HitGen | 525.57M |
| Chengzhi | 11.53B |
| Chengdu Easton Biopharmaceuticals | 1.33B |
| Chongqing Genrix Biopharmaceutical | 230.72M |
| Hualan Biological Vaccine | 976.44M |